The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The digital dose inhalers market size has grown exponentially in recent years, with a projection to increase from $16.08 billion in 2023 to $19.60 billion in 2024, representing a compound annual growth rate (CAGR) of 21.9%. This historical growth is attributed to the rise in respiratory diseases, the increasing adoption of digital dose inhalers, the need for effective monitoring of dosing dates and times, the growing geriatric population, and a heightened emphasis on customized healthcare. The market size for digital dose inhalers is anticipated to see further exponential growth, reaching $43.38 billion in 2028 at a CAGR of 22.0%. The growth in the forecast period is driven by the rise of telemedicine, increasing prevalence of respiratory diseases, a growing need for improved medication adherence and management, and rising consumer awareness. Major trends expected during this period include the integration of digital technologies, enhanced consumer awareness and education, cost-effectiveness, integration with IoT and AI, and growth in telemedicine.

The rising prevalence of chronic respiratory diseases is expected to propel the growth of the digital dose inhalers market moving forward. Chronic respiratory diseases are long-term conditions that affect the lungs and airways, leading to persistent breathing difficulties. The increasing incidence of chronic respiratory diseases can be linked to multiple factors, including heightened air pollution, an aging population, and increasing tobacco use. Digital dose inhalers are instrumental in enhancing medication adherence and monitoring for patients with conditions such as asthma and chronic obstructive pulmonary disease (COPD). For instance, in March 2022, the Centers for Disease Control and Prevention, a U.S. national public health agency, reported an increase in tuberculosis infections in 2021, with a total of 7,860 cases reported, rising from 7,173 cases in 2020. Thus, the growing prevalence of chronic respiratory diseases is driving the growth of the digital dose inhalers market.

Get A Free Sample On The Digital Dose Inhalers Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18807&type=smp

What Are The Key Trends That Influence Digital Dose Inhalers Market Share Analysis?

Major companies in the digital dose inhalers market are focused on creating innovative products, such as smart inhalers, to improve patient outcomes and medication management. Smart inhalers are advanced devices equipped with sensors and connectivity features that monitor drug usage, inhalation technique, and adherence while providing real-time feedback via mobile applications. For example, in June 2024, Aseptika Ltd., a UK-based healthcare company, unveiled the PUFFClicker3 universal smart inhaler dose tracker at the Med-Tech Innovation Expo. The PUFFClicker3 is the world’s first inhaler dose tracker compatible with both pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI), supporting 101 SNOMED-coded inhaler types. This innovation simplifies the transition between different inhaler types for patients and includes built-in graphical instructions for using each supported inhaler.

Which Market Players Are Driving Growth In The Digital Dose Inhalers Market?

Major companies operating in the digital dose inhalers market are AstraZeneca plc, Novartis AG, 3M Company, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., C.H. Boehringer Sohn AG & Co. KG, AptarGroup Inc., Cipla Limited, Chiesi Farmaceutici S.p.A., Lupin Limited, Glenmark Pharmaceuticals Limited, OPKO Health Inc., Nemera, Sensirion AG, Sunovion Pharmaceuticals Inc., MannKind Corporation, Adherium Limited, H&T Presspart, Monaghan Medical Corporation, BreatheSuite Inc.

How Is The Global Digital Dose Inhalers Market Segmented?

The digital dose inhalers market covered in this report is segmented –

1) By Product: Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)
2) By Type: Branded Medication, Generic Medication
3) By Indications: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications
4) By End User: Medical Device Industry, Hospital

Read The Full Digital Dose Inhalers Market Report Here

https://www.thebusinessresearchcompany.com/report/digital-dose-inhalers-global-market-report

The Digital Dose Inhalers Global Market Report 2024 provides an overview of the digital dose inhalersmarket for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The digital dose inhalers market forecast analyzes digital dose inhalers market size, digital dose inhalers market share, leading competitor and their market positions.

The Table Of Content For The Digital Dose Inhalers Market Include

1. Digital Dose Inhalers Market Executive Summary
2. Digital Dose Inhalers Market Segments
3. Digital Dose Inhalers Market Size And Template Market Growth Rate
4.  Key Digital Dose Inhalers Market Trends
5. Major Digital Dose Inhalers Market Drivers
……
25. Key Mergers And Acquisitions In The Digital Dose Inhalers Market
26. Top Digital Dose Inhalers Companies
27. Digital Dose Inhalers Market Opportunities And Strategies
28. Digital Dose Inhalers Market, Conclusions And Recommendations
29. Appendix

Explore Similar Reports From The Business Research Company:

Respiratory Inhaler Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report

Dry Powder Inhaler Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

Smart Inhalers Global Market Report 2024

https://www.thebusinessresearchcompany.com/sample_request?id=14196&type=smp

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: